SCHEMBL19283316

SCHEMBL19283316

O=C(NN=Cc1ccccc1O)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 1.00
MAOA P21397 1/20 1.00
MAOB P27338 1/20 1.00
NPC1 O15118 3/20 0.74
RAB9A P51151 2/20 0.74
HTT P42858 1/20 0.74
L3MBTL1 Q9Y468 1/20 0.74
CA12 O43570 1/20 0.72
CA1 P00915 1/20 0.72
CA2 P00918 1/20 0.72
CA9 Q16790 1/20 0.72
KMT2A Q03164 4/20 0.70
GCGR P47871 2/20 0.70
MAPT P10636 1/20 0.68
PKM P14618 1/20 0.68
ATM Q13315 1/20 0.68
MEN1 O00255 3/20 0.68
KDM4E B2RXH2 1/20 0.68
TP53 P04637 1/20 0.68
CYP3A4 P08684 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15176803 1.00 KDM1A (1.00) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL14712666 1.00 KDM1A (1.00) KDM1AMAOAMAOBNPC1RAB9A
Salicylaldehyde Benzoyl Hydrazone SCHEMBL30193248 0.90 KDM1A (0.82) KDM1AMAOAMAOBNPC1RAB9A
Salicylaldehyde Benzoyl Hydrazone SCHEMBL414977 0.90 KDM1A (0.82) KDM1AMAOAMAOBNPC1RAB9A
Salicylaldehyde Benzoyl Hydrazone SCHEMBL414978 0.90 KDM1A (0.82) KDM1AMAOAMAOBNPC1RAB9A
Salicylaldehyde Benzoyl Hydrazone SCHEMBL6638532 0.90 KDM1A (0.82) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL15853740 0.89 KDM1A (0.81) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL12746361 0.89 KDM1A (0.81) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL10026701 0.88 KDM1A (0.78) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL684821 0.88 KDM1A (0.78) KDM1AMAOAMAOBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS CHOUDHARY MUHAMMAD IQBAL (PK) 2017-08-31 US claimed
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS CHOUDHARY MUHAMMAD IQBAL (PK) 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS TYMP, DPYD, FLT4 KDM1A 732/4885MAOA 1582/4885MAOB 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.